Developer docs
API playgroundTry for free, no card

Search company profiles

Retina Consultants of America

Full company profile

uuid0006vin

Namestring
Retina Consultants of America
Legal namestring
Retina Consultants of America
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Retina Consultants of America is a physician-led management services organization that operates a national network of 30+ retina practices with nearly 300 fellowship-trained retina specialists across 23+ U.S. states. Founded in 2019 and headquartered in Southlake, Texas, RCA provides business-level support — including administration, IT, payor contracting, compliance, and marketing — to affiliated practices whose physicians retain independent clinical decision-making authority. The network includes major regional platforms such as Retina Consultants of Texas (24 Houston/San Antonio locations, 100,000+ annual patients, 190+ active clinical trials), Vitreoretinal Consultants of NY (19 physicians), Illinois Retina Associates (13 Chicago-area locations), Retinal Consultants Medical Group (13 Northern California locations), and Tennessee Retina, among others.

The company's core technology platform centers on advanced retinal diagnostics — particularly high-density OCT imaging — delivered at scale across the network. RCA Research, the organization's clinical trials division, runs a substantial portfolio of active studies, giving the network preferred-partner status with biopharma sponsors and early access to investigational therapies for age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and geographic atrophy. The company is investing in oculomics research, using AI to analyze retinal imaging for biomarkers of systemic disease (Alzheimer's, cardiovascular, and metabolic conditions).

RCA's business model is an MSO/physician services model: revenue is generated through insurance-reimbursed clinical encounters — anti-VEGF injections, laser treatments, and vitreoretinal surgery — with physicians maintaining clinical autonomy while the corporate entity captures scale economics on the business side. RCA was acquired by Cencora Inc. (formerly AmerisourceBergen) for approximately $4.6 billion in January 2025, and is expanding further via the announced $1.1 billion acquisition of EyeSouth Partners' retina business.

Short descriptiontext

Retina Consultants of America is a physician-led MSO operating a national network of 30+ retina practices with nearly 300 specialists across 23+ states. Acquired by Cencora for $4.6 billion in January 2025, RCA provides business support while affiliated physicians retain clinical autonomy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSouthlake, United States
HQ citystring
Southlake
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
retinal care services, physician practice management, clinical research trials, vitreoretinal medical care, ophthalmology specialty network
Industry4 codes
1Retina & Vitreous Specialists
CodeHLAKAKAEPrimaryYes
2Managed Vision Care Networks (Provider Network Management)
CodeHLAEAJAJPrimaryNo
3Ocular Imaging & Diagnostic Testing Centers
CodeHLAKAKANPrimaryNo
4Ophthalmology Specialty Pharmaceuticals
CodeHLAIACAKPrimaryNo
NAICS code2 codes
  • Offices of Optometrists62132
  • Diagnostic Imaging Centers621512
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Facilities Support Management Services8744
Product category
Specialty Retinal Healthcare Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Specialty Healthcare Services
TypeManaged Services
Description

RCA operates as a Management Services Organization providing business support to affiliated retina practices. Revenue is generated through healthcare service delivery including diagnostic procedures, medical treatments, and surgical interventions for retinal conditions. The MSO model provides administrative, operational, and strategic support while physicians deliver clinical care.

intuitionlabs.ai
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Healthcare services provided through insurance-covered medical treatments
ModelOtherBilling cadencePay-as-you-go
Notes

Retina care services including anti-VEGF injections, laser treatments, and surgeries are typically covered by health insurance including Medicare Part B. Geographic atrophy treatments (Syfovre, Izervay) are also FDA-approved medications typically covered by insurance. Specific out-of-pocket costs vary by insurance plan, procedure type, and patient circumstances.

retinaconsultantsofamerica.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1RCA Research
Description

Clinical research division of Retina Consultants of America focused on groundbreaking clinical trials and advancing retinal care treatments

retinaconsultantsofamerica.com
+1 more record
Core offering1 text field

Retina Consultants of America operates a nationwide network of fellowship-trained retina specialists delivered through 30+ affiliated partner practices. The organization functions as a physician-led Management Services Organization (MSO) that provides business, operational, technology, and clinical research support to independent retina practices while physicians retain clinical decision-making authority. Core services include diagnostic imaging (OCT), anti-VEGF injections, laser treatments, and vitreoretinal surgery for conditions such as macular degeneration, diabetic retinopathy, retinal detachment, and geographic atrophy, with revenue generated through insurance-reimbursed medical services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Retina Consultants of America is a physician-led network of elite retina practices operating as a unified platform. The core offering is the RCA Network, which comprises 30+ partner practices across 23+ states (including Retina Consultants of Texas, Vitreoretinal Consultants of NY, Retinal Consultants Medical Group, and others), all supported by business-level resources while maintaining clinical autonomy. The network also includes RCA Research (rcaresearch.com), which conducts clinical trials for new treatments. The platform provides patients access to retina specialists through a Find a Doctor locator tool. The company was acquired by Cencora (formerly AmerisourceBergen) for $4.6 billion in January 2025 and is expanding through pending acquisition of EyeSouth Partners' retina business for $1.1 billion.

Product and service4 records
1Retina Consultants of America Network
CategorySpecialty Retinal Healthcare Services
Description

A nationwide network of 30+ elite retina practices supported by centralized business services. Provides adult patients access to fellowship-trained retina specialists for diagnosis, medical treatment, surgical intervention, and clinical trial enrollment across 20+ U.S. states.

2RCA Research Clinical Trials Program
CategoryClinical Research Services
Description

Network-wide clinical trial infrastructure enabling participation in major retinal clinical trials. Retina Consultants of Texas alone operates 190+ active clinical trials. Provides eligible patients access to investigational retinal therapies before commercial availability.

3MSO Practice Partnership Services
CategoryPractice Management Services
Description

Centralized business, administrative, technology, marketing, compliance, and strategic support provided to independent retina practices that join the RCA network. Physicians retain clinical autonomy and decision-making authority while benefiting from MSO-level operational infrastructure.

4Find a Doctor Locator
CategoryPatient Access Platform
Description

Patient-facing online search tool that allows prospective patients to locate RCA network retina specialists by location across 20+ U.S. states.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-23
Description

Cencora announced a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion, with affiliated retina physicians joining Retina Consultants of America. The transaction is expected to enhance access to innovative retina treatments and expand clinical trial involvement. Pending regulatory approval, this acquisition will add EyeSouth's affiliated physicians to the RCA network, expanding the organization's footprint and physician count.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-01-07
Description

Cencora (formerly AmerisourceBergen), a Fortune 25 pharmaceutical solutions organization with over $300 billion in annual revenue, acquired Retina Consultants of America for $4.6 billion in January 2025. The acquisition expands Cencora's specialty healthcare services and positions RCA within a larger healthcare platform. RCA maintains operations as a physician-led MSO while benefiting from Cencora's capital resources and healthcare ecosystem connections.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries23 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Retina Consultants of America

Specialty Retinal Healthcare Servicesretinaconsultantsofamerica.com

Retina Consultants of America is a physician-led MSO operating a national network of 30+ retina practices with nearly 300 specialists across 23+ states. Acquired by Cencora for $4.6 billion in January 2025, RCA provides business support while affiliated physicians retain clinical autonomy.

What Retina Consultants of America does

Retina Consultants of America is a physician-led management services organization that operates a national network of 30+ retina practices with nearly 300 fellowship-trained retina specialists across 23+ U.S. states. Founded in 2019 and headquartered in Southlake, Texas, RCA provides business-level support — including administration, IT, payor contracting, compliance, and marketing — to affiliated practices whose physicians retain independent clinical decision-making authority. The network includes major regional platforms such as Retina Consultants of Texas (24 Houston/San Antonio locations, 100,000+ annual patients, 190+ active clinical trials), Vitreoretinal Consultants of NY (19 physicians), Illinois Retina Associates (13 Chicago-area locations), Retinal Consultants Medical Group (13 Northern California locations), and Tennessee Retina, among others.

The company's core technology platform centers on advanced retinal diagnostics — particularly high-density OCT imaging — delivered at scale across the network. RCA Research, the organization's clinical trials division, runs a substantial portfolio of active studies, giving the network preferred-partner status with biopharma sponsors and early access to investigational therapies for age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and geographic atrophy. The company is investing in oculomics research, using AI to analyze retinal imaging for biomarkers of systemic disease (Alzheimer's, cardiovascular, and metabolic conditions).

RCA's business model is an MSO/physician services model: revenue is generated through insurance-reimbursed clinical encounters — anti-VEGF injections, laser treatments, and vitreoretinal surgery — with physicians maintaining clinical autonomy while the corporate entity captures scale economics on the business side. RCA was acquired by Cencora Inc. (formerly AmerisourceBergen) for approximately $4.6 billion in January 2025, and is expanding further via the announced $1.1 billion acquisition of EyeSouth Partners' retina business.

Retina Consultants of America firmographics

Firmographics
Name
Retina Consultants of America
Legal name
Retina Consultants of America
Website
https://retinaconsultantsofamerica.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
Retina Consultants of America is a physician-led MSO operating a national network of 30+ retina practices with nearly 300 specialists across 23+ states. Acquired by Cencora for $4.6 billion in January 2025, RCA provides business support while affiliated physicians retain clinical autonomy.
Ownership category
akta.pro rank

Retina Consultants of America industry classification

Industry
Product category
Specialty Retinal Healthcare Services
NAICS
Offices of Optometrists (62132), Diagnostic Imaging Centers (621512)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Facilities Support Management Services (8744)
akta.pro primary industry
Retina & Vitreous Specialists (HLAKAKAE)
akta.pro secondary industries
Managed Vision Care Networks (Provider Network Management) (HLAEAJAJ), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN), Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

Keywords

  • Retinal care services
  • Physician practice management
  • Clinical research trials
  • Vitreoretinal medical care
  • Ophthalmology specialty network

Where Retina Consultants of America is headquartered

Location

Headquarters

HQ city
Southlake
HQ country
United States
HQ region
North America

Offices6 records

Markets served

Retina Consultants of America business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Specialty Healthcare Services: RCA operates as a Management Services Organization providing business support to affiliated retina practices. Revenue is generated through healthcare service delivery including diagnostic procedures, medical treatments, and surgical interventions for retinal conditions. The MSO model provides administrative, operational, and strategic support while physicians deliver clinical care.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goHealthcare services provided through insurance-covered medical treatments

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Retina Consultants of America product offering

Product offering

Core offering

Retina Consultants of America operates a nationwide network of fellowship-trained retina specialists delivered through 30+ affiliated partner practices. The organization functions as a physician-led Management Services Organization (MSO) that provides business, operational, technology, and clinical research support to independent retina practices while physicians retain clinical decision-making authority. Core services include diagnostic imaging (OCT), anti-VEGF injections, laser treatments, and vitreoretinal surgery for conditions such as macular degeneration, diabetic retinopathy, retinal detachment, and geographic atrophy, with revenue generated through insurance-reimbursed medical services.

Product overview

Retina Consultants of America is a physician-led network of elite retina practices operating as a unified platform. The core offering is the RCA Network, which comprises 30+ partner practices across 23+ states (including Retina Consultants of Texas, Vitreoretinal Consultants of NY, Retinal Consultants Medical Group, and others), all supported by business-level resources while maintaining clinical autonomy. The network also includes RCA Research (rcaresearch.com), which conducts clinical trials for new treatments. The platform provides patients access to retina specialists through a Find a Doctor locator tool. The company was acquired by Cencora (formerly AmerisourceBergen) for $4.6 billion in January 2025 and is expanding through pending acquisition of EyeSouth Partners' retina business for $1.1 billion.

Differentiator

Problem solved

Functional benefit

Brands

  • RCA Research: Clinical research division of Retina Consultants of America focused on groundbreaking clinical trials and advancing retinal care treatments
  • RCA

Products and services

  • Retina Consultants of America Network A nationwide network of 30+ elite retina practices supported by centralized business services. Provides adult patients access to fellowship-trained retina specialists for diagnosis, medical treatment, surgical intervention, and clinical trial enrollment across 20+ U.S. states.
  • RCA Research Clinical Trials Program Network-wide clinical trial infrastructure enabling participation in major retinal clinical trials. Retina Consultants of Texas alone operates 190+ active clinical trials. Provides eligible patients access to investigational retinal therapies before commercial availability.
  • MSO Practice Partnership Services Centralized business, administrative, technology, marketing, compliance, and strategic support provided to independent retina practices that join the RCA network. Physicians retain clinical autonomy and decision-making authority while benefiting from MSO-level operational infrastructure.
  • Find a Doctor Locator Patient-facing online search tool that allows prospective patients to locate RCA network retina specialists by location across 20+ U.S. states.

Companies that use Retina Consultants of America

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Retina Consultants of America technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Retina Consultants of America partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and flagship.

  • EyeSouth PartnerscoreStrategic or Co-development Partner · 23 March 2026Cencora announced a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion, with affiliated retina physicians joining Retina Consultants of America. The transaction is expected to enhance access to innovative retina treatments and expand clinical trial involvement. Pending regulatory approval, this acquisition will add EyeSouth's affiliated physicians to the RCA network, expanding the organization's footprint and physician count.
  • Cencora, Inc.flagshipStrategic or Co-development Partner · 7 January 2025Cencora (formerly AmerisourceBergen), a Fortune 25 pharmaceutical solutions organization with over $300 billion in annual revenue, acquired Retina Consultants of America for $4.6 billion in January 2025. The acquisition expands Cencora's specialty healthcare services and positions RCA within a larger healthcare platform. RCA maintains operations as a physician-led MSO while benefiting from Cencora's capital resources and healthcare ecosystem connections.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Retina Consultants of America competitors and assessment

Company assessment

Market position

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Retina Consultants of America social profiles

Digital presence

Retina Consultants of America financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Retina Consultants of America leadership team

Management profile

Number of profiles

Retina Consultants of America subsidiaries and ownership

Company hierarchy

Subsidiaries23 records

Retina Consultants of America funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Retina Consultants of America M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina Consultants of America

What does Retina Consultants of America do?

Retina Consultants of America operates a nationwide network of fellowship-trained retina specialists delivered through 30+ affiliated partner practices. The organization functions as a physician-led Management Services Organization (MSO) that provides business, operational, technology, and clinical research support to independent retina practices while physicians retain clinical decision-making authority. Core services include diagnostic imaging (OCT), anti-VEGF injections, laser treatments, and vitreoretinal surgery for conditions such as macular degeneration, diabetic retinopathy, retinal detachment, and geographic atrophy, with revenue generated through insurance-reimbursed medical services.

Is Retina Consultants of America a public or private company?

Retina Consultants of America is a private company. It is classified as corporate owned and is currently operating.

When was Retina Consultants of America founded?

Retina Consultants of America was founded in 2019. It employs 51 to 100 people.

Where is Retina Consultants of America based?

Retina Consultants of America is headquartered in Southlake, United States, in the North America region.

How does Retina Consultants of America make money?

One revenue line is on record: specialty Healthcare Services.

Does Retina Consultants of America have an API?

No public API is recorded for Retina Consultants of America.

What industry is Retina Consultants of America in?

Retina Consultants of America's product category is Specialty Retinal Healthcare Services. Its primary akta.pro industry code is HLAKAKAE, Retina & Vitreous Specialists, with a secondary code of HLAEAJAJ, Managed Vision Care Networks (Provider Network Management). Its NAICS code is 62132 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogPhysicians Across Retina Consultants of America Network to Present Key Trial Data and Clinical Insights at ASRS 2026Retina Consultants of America (RCA) announced that physicians from its network will present over 30 sessions at the American Society of Retina Specialists (ASRS) 44th Annual Meeting, July 15-18, featuring late-breaking clinical trial data on gene therapy for neovascular age-related macular degeneration and phase 3 outcomes for a novel anti-VEGF agent for diabetic retinopathy. The research highlights include novel surgical techniques for macular holes and AI applications for predicting retinal tear locations, reflecting advances across vitreoretinal disease management. Two RCA-affiliated physicians will receive prestigious ASRS awards recognizing contributions to vitreoretinal surgery, treatment, and research.PharmiWeb.comCencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina BusinessCencora, Inc. announced the signing of a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion, with affiliated retina physicians set to join Cencora's Retina Consultants of America (RCA) upon closing. The transaction is expected to be slightly accretive, net of financing costs, to Cencora's adjusted diluted EPS within the first twelve months following closing, subject to customary conditions and regulatory approvals. Cencora reaffirmed its fiscal 2026 financial guidance, which does not currently contemplate the transaction closing in fiscal 2026.BeckersascOphthalmology dealmaking slows after PE boom: 7 notesOphthalmology deal volume has fallen to multi-year lows in 2024-2025 after peaking during the private equity boom of 2020-2022, with fewer than 100 groups transacting compared to over 300 in 2021. Despite the slowdown, two major deals closed—Cencora's acquisition of Retina Consultants of America and McKessesson's $850 million acquisition of an 80% stake in Prism Vision Holdings—while acquirers increasingly prioritize high-quality practices in existing markets for geographic density. Industry observers expect continued selective dealmaking through 2026, citing normalized valuations and physician preference for independence, though long-term optimism persists due to aging demographics and ophthalmic service innovation.GlobeNewswireCross Keys Capital Advises Montana Retina Consultants in Its Partnership with Retina Consultants of AmericaCross Keys Capital acted as exclusive financial advisor to Montana Retina Consultants in its partnership with Retina Consultants of America. The Bozeman-based retinal care practice will benefit from RCA's resources and collaborative network. The deal team included Jeanne Proia, Chris Gammill, and Andres Poveda.ClearlyacquiredAverage EBITDA Multiples for Healthcare and Medical PracticesThis article provides an overview of how EBITDA multiples are used to value healthcare and medical practices across specialties, noting that median healthcare services multiples declined to 11.5× in 2025 from 14.5× in 2024, with significant variation depending on practice size, specialty, and payer mix. Larger practices with EBITDA exceeding $5 million and those with over 70% commercial insurance revenue consistently achieve the highest valuations, often commanding 2–4× higher multiples than smaller counterparts. Notable recent transactions highlighting these valuation trends include Cardinal Health's $2.8 billion acquisition of GI Alliance and Cencora's $4.6 billion acquisition of Retina Consultants of America.BainNew Models of Value Creation for Physician GroupsPrivate equity investment in physician groups has declined as a share of global provider deals from 28% in 2021 to 23% in 2025, driven by post-pandemic headwinds including labor shortages and reimbursement pressure, particularly in the US market which accounts for over 60% of global provider deal value. The value-creation playbook for physician group investments has evolved beyond traditional buy-and-build strategies to emphasize operational efficiency through AI and analytics, physician alignment, and ancillary expansion. Notable recent transactions include Cardinal Health's GI Alliance acquiring Solaris Health from Lee Equity Partners, Cencora's acquisition of Retina Consultants of America, and McKesson's acquisition of Prism Vision Group, reflecting broadening interest from distributors and strategic acquirers.KPMGM&A trends in healthcareHealthcare M&A activity in H1 2025 remained steady with 415 deals (down 1.0% from H2'24) while total deal value surged 56.0% to $34.7 billion, driven by strategic buyers accounting for 60.2% of volume. The healthcare services sector led with 231 deals and a 549.8% value increase to $20.8 billion, while payers saw a sharp contraction with 54.0% fewer transactions amid Medicare Advantage regulatory uncertainty. Top transactions included Cencora's $4.4 billion acquisition of Retina Consultants of America and Ascension's $3.9 billion purchase of AMSURG.The Globe and MailHere's Why You Should Hold Cencora Stock in Your Portfolio NowCencora reported Q2 fiscal 2025 EPS of $4.00, up 19.8% year over year, and revenues of $80.7 billion, up 8.7%. The company raised its fiscal 2025 adjusted EPS estimate to $15.85–$16.00, implying 15–16% growth. It also acquired Retina Consultants of America to expand specialty capabilities.VmghealthA New Buyer in Physician Practice M&A EmergesStrategic buyers including pharmaceutical distributors and insurers are driving a rebound in physician practice M&A activity despite macroeconomic and regulatory headwinds. Notable transactions include Cencora's $4.6 billion acquisition of Retina Consultants of America and Cardinal Health's $2.8 billion purchase of GI Alliance, reflecting a shift toward vertical integration and care delivery control.LexologyQuarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and AcquisitionsHealthcare services M&A deal volume fell 10.4% in Q4 2024, down 11.7% year-over-year. Notable deals included NeueHealth, Cross Country Healthcare, and Retina Consultants of America. The sector remains below pandemic levels, with 2025 activity expected to depend on interest rates and regulatory changes.